XM does not provide services to residents of the United States of America.
S
S

Scor

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

FLSmidth, Neste, Sonova Holding

EUROPE RESEARCH ROUNDUP- FLSmidth, Neste, Sonova Holding May 20 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including FLSmidth, Neste and Sonova Holding, on Monday. HIGHLIGHTS * FLSmidth FLS.CO : JP Morgan raises target price to DKK 400 from DKK 310 * IMCD NV IMCD.AS : JP Morgan cuts target price to EUR 185 from EUR 188 * Neste Oyj NESTE.HE : Stifel cuts target price to EUR 37 from EUR 40 * Sonova Holding AG SOON.S : Morgan Stanley cuts
B
C
C
E
E
E
F
F
G
N
P
R
S
S
S
S
T
U
U
V
A
F
R

European shares end lower on rate cut jitters; Richemont shines

UPDATE 2-European shares end lower on rate cut jitters; Richemont shines For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Azelis notches worst day ever after EQT, PSP sell shares Lagercrantz tops STOXX after Q4 report Fitch's credit rating review on Spain on tap ECB's Schnabel calls for caution in rate cuts beyond June Updated at 1600 GMT By Ankika Biswas and Johann M Cherian May 17 (Reuters) - European shares closed lower on Friday, as
A
E
R
S
S
H
E
F
S
U
G

Market presses pause on STOXX rally

LIVE MARKETS-Market presses pause on STOXX rally Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com MARKET PRESSES PAUSE ON STOXX RALLY The STOXX 600 .STOXX is ticking down 0.3%, on track for its biggest daily drop so far in May - partly a reflection of how many days of gains it has had in recent weeks.
H
R
S
E
F
U
G

Scor hits bottom of SBF 120 after Q1 profit miss

BUZZ-Scor hits bottom of SBF 120 after Q1 profit miss ** Shares in Scor SCOR.PA fall more than 8% after the French reinsurance company's Q1 results miss expectations ** The group's net income was 196 million euros ($213 million), which J.P.Morgan says is 6% below consensus ** JPM says the miss was driven by a weaker insurance service result in Scor's Life & Health division ** Jefferies notes a negative impact of the U.S mortality on Life & Health ** This is especially disappointing given that Mu
S

Scor: In L&H, We Are Impacted By An Adverse Experience Variance-CEO

BRIEF-Scor: In L&H, We Are Impacted By An Adverse Experience Variance-CEO May 17 (Reuters) - Scor SE SCOR.PA : FIRST QUARTER 2024 RESULTS: SCOR STARTS 2024 WITH A STRONG FIRST THREE-MONTHS NET INCOME OF EUR 196 MILLION IN L&H, WE ARE IMPACTED BY AN ADVERSE EXPERIENCE VARIANCE, MAINLY DRIVEN BY US MORTALITY AND CLAIMS REPORTING EFFECTS - CEO IN P&C,
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.